Resectable Oropharyngeal Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Resectable Oropharyngeal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery (NCT04588038) | Hyunseok Kang, MD | 2021-03-12 |
Track Resectable Oropharyngeal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.